Net Cash Provided by (Used in) Investing Activities of DMK PHARMACEUTICALS Corp from 30 Jun 2010 to 31 Mar 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Summary
DMK PHARMACEUTICALS Corp quarterly and annual Net Cash Provided by (Used in) Investing Activities in USD history and change rate from 30 Jun 2010 to 31 Mar 2023.
  • DMK PHARMACEUTICALS Corp Net Cash Provided by (Used in) Investing Activities for the quarter ending 31 Mar 2023 was $841,778, a 45% decline year-over-year.
  • DMK PHARMACEUTICALS Corp annual Net Cash Provided by (Used in) Investing Activities for 2022 was $3,483,909, a 1132% increase from 2021.
  • DMK PHARMACEUTICALS Corp annual Net Cash Provided by (Used in) Investing Activities for 2021 was $282,737.
  • DMK PHARMACEUTICALS Corp annual Net Cash Provided by (Used in) Investing Activities for 2020 was $946,214, a 67% increase from 2019.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Investing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Investing Activities, Annual (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Annual Change (%)

DMK PHARMACEUTICALS Corp Quarterly Net Cash Provided by (Used in) Investing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2023 $841,778 -$690,934 -45% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q1 2022 $1,532,712 +$1,938,897 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q1 2021 $406,185 -$131,876 -48% 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022 2022 Q1
Q1 2020 $274,309 +$1,391,599 +84% 01 Jan 2020 31 Mar 2020 10-Q 22 Nov 2021 2021 Q1
Q1 2019 $1,665,908 -$1,464,732 -728% 01 Jan 2019 31 Mar 2019 10-Q 18 May 2020 2020 Q1
Q1 2018 $201,176 -$137,014 -214% 01 Jan 2018 31 Mar 2018 10-Q 09 May 2019 2019 Q1
Q1 2017 $64,162 01 Jan 2017 31 Mar 2017 10-Q 10 May 2018 2018 Q1
Q2 2011 $500,000 +$125,000 +33% 01 Apr 2011 30 Jun 2011 10-Q/A 17 Aug 2012 2012 Q1
Q2 2010 $375,000 01 Apr 2010 30 Jun 2010 10-Q 15 Aug 2011 2011 Q1

DMK PHARMACEUTICALS Corp Annual Net Cash Provided by (Used in) Investing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2022 $3,483,909 +$3,201,172 +1132% 01 Jan 2022 31 Dec 2022 10-K 16 Mar 2023 2022 FY
2021 $282,737 +$1,228,951 01 Jan 2021 31 Dec 2021 10-K 16 Mar 2023 2022 FY
2020 $946,214 +$1,920,204 +67% 01 Jan 2020 31 Dec 2020 10-K 31 Mar 2022 2021 FY
2019 $2,866,418 +$668,946 +19% 01 Jan 2019 31 Dec 2019 10-K 15 Apr 2021 2020 FY
2018 $3,535,364 -$1,447,406 -69% 01 Jan 2018 31 Dec 2018 10-K 30 Mar 2020 2019 FY
2017 $2,087,958 -$2,348,706 -901% 01 Jan 2017 31 Dec 2017 10-K 15 Mar 2019 2018 FY
2016 $260,748 01 Jan 2016 31 Dec 2016 10-K 16 Mar 2018 2017 FY
2013 $10,000,000 01 Apr 2013 31 Mar 2014 10-K 23 Jun 2014 2014 FY
2010 $150,000 01 Apr 2010 31 Mar 2011 10-K 29 Jun 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.